The Patented Medicine Prices Review Board (PMPRB) invites stakeholders to comment on three proposed amendments to the new PMPRB Guidelines related to the decision to delay the coming-into-force date of the Regulations Amending the Patented Medicines Regulations (“Regulations”) a further six months, from July 1, 2021 to January 1, 2022. The PMPRB proposes to change the definition of Gap medicines, the references to the comparator countries and the international price tests for Grandfathered medicines and their line extensions.
The deadline to submit written comments is August 15, 2021. Only feedback submitted to the PMPRB Consultations inbox will be accepted for consideration.
For more information about this feedback period on the PMPRB Guidelines, please visit our Notice and Comment webpage:
Consistent with our commitment to transparency, the PMPRB intends to make the written submissions publicly available on our website.
All future announcements of this type will be communicated through the PMPRB Twitter account.